Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02446444
Title Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer
Acronym ENZARAD
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors University of Sydney
Indications
Therapies
Age Groups: adult
Covered Countries USA | NZL | GBR | ESP | BEL | AUT | AUS


No variant requirements are available.